The Fund aims to provide long-term capital growth.
Name | % Net Assets |
---|---|
BP | 7.6% |
Vodafone | 5.6% |
GlaxoSmithKline | 4.9% |
Royal Dutch Shell A | 4.8% |
HSBC | 4.1% |
Royal Dutch Shell B | 3.6% |
FTSE 100 20/06/09 Future | 3.2% |
AstraZeneca | 3.1% |
BG Group | 3.1% |
British American Tobacco | 2.8% |
Key | % Net Assets |
---|---|
BP | 7.6% |
Vodafone | 5.6% |
GlaxoSmithKline | 4.9% |
Royal Dutch Shell A | 4.8% |
Other | 77.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 901.70p |
Currency | GBP |
Change | 3.60p |
% | 0.40% |
YTD change | 68.80p |
YTD % | 8.26% |
Fund Inception | 15/09/1988 |
---|---|
Fund Manager | Terry Wood |
TER | 0.38 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.30% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.09 |
You are here: research